loading page

PARP-inhibitors in a non‐oncological indication as COVID-19: are we aware about its potential role as anti-thrombotic drugs? The discussion is open.
  • Ettore Capoluongo
Ettore Capoluongo
University of Naples Federico II School of Medicine and Surgery
Author Profile

Peer review status:Published

Oct 2020Published in Biomedicine & Pharmacotherapy volume 130 on pages 110536. 10.1016/j.biopha.2020.110536